UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Calorie and nutrient contribution of alcoholic beverages to the usual diets of 155 adults

The American journal of clinical nutrition, 1971-09, Vol.24 (9), p.1042-1052

1971

Volltextzugriff (PDF)

Drinking practices recorded by a diary method

Quarterly journal of studies on alcohol, 1972-12, Vol.33 (4), p.1106

1972

Volltextzugriff (PDF)

Nutritive content of the usual diets of eighty-two men

Journal of the American Dietetic Association, 1972-10, Vol.61 (4), p.407-415

1972

Volltextzugriff (PDF)

Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline

Canadian Medical Association journal (CMAJ), 2015-12, Vol.187 (18), p.1369

2015

Volltextzugriff (PDF)

Exercise preferences, levels and quality of life in lung cancer survivors

Supportive care in cancer, 2015-11, Vol.23 (11), p.3239-3247

2015

Volltextzugriff (PDF)

Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011

Current oncology (Toronto), 2017-12, Vol.24 (6), p.e486-493

2017

Volltextzugriff (PDF)

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective

Current oncology (Toronto), 2019-08, Vol.26 (4), p.e551-557

2019

Volltextzugriff (PDF)

Internal Clock Processes and the Filled-Duration Illusion

Journal of experimental psychology. Human perception and performance, 2007-06, Vol.33 (3), p.716-729

2007

Volltextzugriff (PDF)

Reaching the pinnacle of stage III NSCLC treatment

Annals of oncology, 2016-10, Vol.27, p.vi414-vi414

2016

Volltextzugriff (PDF)

P2.17-01 Recent Patterns across Therapy Lines and Real-World Survival Post First Line PD-L1 Treatment for Small Cell Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S377-S378

2023

Volltextzugriff (PDF)

EP13.07-03 Treatment Patterns and Outcomes in Recent US Clinical Practice for SCLC Patients After Two Prior Lines of Therapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S706-S707

2023

Volltextzugriff (PDF)

Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner

Gut, 2003-10, Vol.52 (10), p.1408-1413

2003

Volltextzugriff (PDF)

P2.01-026 Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2078-S2079

2017

Volltextzugriff (PDF)

P09.08 Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S290-S290

2021

Volltextzugriff (PDF)

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

The Journal of pathology, 2004-09, Vol.204 (1), p.101-109

2004

Volltextzugriff (PDF)

P1359Extent and treatment of acute coronary syndrome in coronary care units: cross-sectional survey of 32 ESC-member countries

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

P2.01-13 Number, Rather Than Location of Metastases, Dictates Outcome in Stage IV, M1b, Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S669-S670

2018

Volltextzugriff (PDF)

MA14.11 Factors Associated with Early Mortality in Non-Small Cell Lung Cancer Patients Following Systemic Anti-Cancer Treatment

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S406-S407

2018

Volltextzugriff (PDF)

P2.01-28 Gender and Systemic Treatment Patterns: Impacts on the Overall Survival of Stage IV NSCLC 2010 – 2014 Diagnoses

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S675-S675

2018

Volltextzugriff (PDF)

P1.03-043 30-Day Mortality Following Systemic Anti-Cancer Treatment for NSCLC at a Single Canadian Cancer Centre

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1967-S1967

2017

Volltextzugriff (PDF)

P1.06-006 Survival Benefits and Associated Prognostic Factors among Young NSCLC Patients

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1988-S1988

2017

Volltextzugriff (PDF)

P2.01-046 Clinical Characteristics of Survival with De Novo Versus Relapsed Metastatic Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2087-S2087

2017

Volltextzugriff (PDF)

Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer

Genomics (San Diego, Calif.), 1992-07, Vol.13 (3), p.718-725

1992

Volltextzugriff (PDF)

A New Normal for Accounts of Causation

Bebb, Jonathan H

2021

Volltextzugriff (PDF)

P2.02-068 BRG1 and p53 Expression in Resected Stage I – III Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2125-S2125

2017

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(82)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Calorie and nutrient contribution of alcoholic beverages to the usual diets of 155 adults

Drinking practices recorded by a diary method

Nutritive content of the usual diets of eighty-two men

Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline

Exercise preferences, levels and quality of life in lung cancer survivors

Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective

Internal Clock Processes and the Filled-Duration Illusion

Reaching the pinnacle of stage III NSCLC treatment

P2.17-01 Recent Patterns across Therapy Lines and Real-World Survival Post First Line PD-L1 Treatment for Small Cell Lung Cancer

EP13.07-03 Treatment Patterns and Outcomes in Recent US Clinical Practice for SCLC Patients After Two Prior Lines of Therapy

Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner

P2.01-026 Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer

P09.08 Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

P1359Extent and treatment of acute coronary syndrome in coronary care units: cross-sectional survey of 32 ESC-member countries

P2.01-13 Number, Rather Than Location of Metastases, Dictates Outcome in Stage IV, M1b, Non-Small Cell Lung Cancer

MA14.11 Factors Associated with Early Mortality in Non-Small Cell Lung Cancer Patients Following Systemic Anti-Cancer Treatment

P2.01-28 Gender and Systemic Treatment Patterns: Impacts on the Overall Survival of Stage IV NSCLC 2010 – 2014 Diagnoses

P1.03-043 30-Day Mortality Following Systemic Anti-Cancer Treatment for NSCLC at a Single Canadian Cancer Centre

P1.06-006 Survival Benefits and Associated Prognostic Factors among Young NSCLC Patients

P2.01-046 Clinical Characteristics of Survival with De Novo Versus Relapsed Metastatic Non-Small Cell Lung Cancer

Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer

A New Normal for Accounts of Causation

P2.02-068 BRG1 and p53 Expression in Resected Stage I – III Non-Small Cell Lung Cancer

Suchergebnisse filtern